Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression
Ramona Schulz(University of Göttingen), Ute M. Moll(Stony Brook University)
Cited by 121
Related Papers
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
|Proceedings of the National Academy of Sciences|1992|580
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
|Proceedings of the National Academy of Sciences|1995|433
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
|Cell Death and Differentiation|2011|331
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
|The Journal of Experimental Medicine|2002|317
Mitochondrially Targeted p53 Has Tumor Suppressor Activities <i>In vivo</i>
|Cancer Research|2005|74